Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00870 | SPB | 858128-57-1 |
| SPB is a drug-linker conjugate for ADC with potent anti-inflammatory activity by using Xanthotoxol, linked via the ADC linker. | Inquiry | |
| BADC-00018 | sulfo-SPDB-DM4 | 1626359-59-8 |
| DM4 with a reactive linker sulfo-SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. | Inquiry | |
| BADC-00030 | BA-3011 | |
| BA-3011 is a novel conditionally active biologic AXL-targeted antibody-drug conjugate used to treat solid tumor. The CAB technology is aimed to improve the selectivity of BA-3011 for binding to AXL receptor on cancer cells. | Inquiry | |
| BADC-00852 | Mc-Dexamethasone | 1618096-56-2 |
| Mc-Dexamethasone is a drug-linker conjugate for ADC. Mc-Dexamethasone is made toxin Dexamethasone (HY-14648) conjugated to the non-cleavable MC linker. Dexamethasone is a glucocorticoid receptor agonist. | Inquiry | |
| BADC-00858 | MC-Val-Cit-PAB-rifabutin | 2055900-34-8 |
| MC-Val-Cit-PAB-rifabutin is a drug-linker conjugate for ADC with potent antitumor activity by using rifabutin (an DNA-dependent RNA polymerase inhibitor), linked via the ADC linker MC-Val-Cit-PAB. | Inquiry | |
| BADC-00859 | DGN549-C | 2058075-34-4 |
| DGN549-C consists a cleavable ADC linker valine-alanine (va) and PBD dimer. DGN549 is a novel DNA-alkylating cytotoxic payload and can be used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01344 | IgG1-VcMMAE | |
| IgG1-VcMMAE is an anti-mesothelin antibody-drug conjugate that eradicates mesothelin-positive human gastric and pancreatic tumors in xenograft models. | Inquiry | |
| BADC-01349 | Azido-PEG4-Glu-Val-Cit-PAB-MMAE | |
| Azido-PEG4-Glu-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC. | Inquiry | |
| BADC-01426 | VA-PAB-DMEA-PNU159682 | 2414872-62-9 |
| VA-PAB-DMEA-PNU159682 is a sortase-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01535 | MC-VC-PAB-Tubulysin M | 1639939-56-2 |
| MC-VC-PAB-Tubulysin M is a potent antibody-drug conjugate used in the treatment of various cancers, including breast, lung, and ovarian cancers. It combines the targeted delivery of an antibody with the cytotoxic effects of Tubulysin M, inhibiting microtubule formation and inducing cell death. | Inquiry | |
| BADC-00029 | MC-Val-Cit-PAB-MMAE | 646502-53-6 |
| MC-Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate. | Inquiry | |
| BADC-00028 | DOXO-EMCH | 151038-96-9 |
| DOXO-EMCH is an albumin-binding prodrug of doxorubicin, which is an anthracycline antibiotic with anti-Gram-positive bacterial activity and a broad antitumor spectrum. | Inquiry | |
| BADC-00027 | INNO-206 | 1361644-26-9 |
| INNO-206 (Aldoxorubicin) is the 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic activity. | Inquiry | |
| BADC-00026 | Mc-MMAD | 1401963-15-2 |
| Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate; Mc-MMAD is a protective group (maleimidocaproyl) -conjugated MMAD. | Inquiry | |
| BADC-00024 | Vc-MMAD | 1401963-17-4 |
| Vc-MMAD consists the ADCs linker(Val-Cit) and potent tubulin inhibitor (MMAD), Vc-MMAD is an antibody drug conjugate. | Inquiry | |
| BADC-00025 | Mc-MMAE | 863971-24-8 |
| Mc-MMAE is a protective group conjugated MMAE, MMAE inhibits tubulin polymerization so that it inhibits cell division. | Inquiry | |
| BADC-00020 | DM1-SMe | 138148-68-2 |
| DM1-SMe is a potent maytansinoid microtubular inhibitor and an unconjugated DM1 as a mixed disulfide with thiomethane to cap its sulfhydryl group. DM1-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). . | Inquiry | |
| BADC-00019 | Fmoc-VC-PAB-MMAE | 1350456-56-2 |
| Fmoc-Val-Cit-PAB-MMAE is an antibody drug conjugate contained Fmoc-Val-Cit-PAB and MMAE and probably have antineoplastic activity. | Inquiry | |
| BADC-00849 | Acetylene-linker-Val-Cit-PABC-MMAE | 1411977-95-1 |
| Acetylene-linker-Val-Cit-PABC-MMAE consists the ADCs linker (Acetylene-linker-Val-Cit-PABC) and potent tubulin inhibitor (MMAE), Acetylene-linker-Val-Cit-PABC-MMAE is an antibody drug conjugate. | Inquiry | |
| BADC-01448 | mDPR-Val-Cit-PAB-MMAE | 1491152-26-1 |
| mDPR-Val-Cit-PAB-MMAE consists the ADCs linker (mDPR-Val-Cit-PAB) and potent tubulin inhibitor (MMAE), mDPR-Val-Cit-PAB-MMAE is an antibody drug conjugate. | Inquiry |
